Literature DB >> 10625029

Psoriasis: current perspectives with an emphasis on treatment.

K G Linden1, G D Weinstein.   

Abstract

An individualized treatment regimen is necessary for each patient with psoriasis because of the diverse nature of the disease. The manifestation of psoriasis, the severity and extent of the lesions, and the medical history and lifestyle of the patient are important factors that determine the selection of treatment, but in general therapies with the fewest side effects are preferred. First-line topical treatments are corticosteroids, calcipotriene, and tazarotene. If topical treatments are unsuccessful, phototherapy with ultraviolet B or photochemotherapy with psoralens plus ultraviolet A (PUVA) are the next choices. If psoriasis fails to respond to an adequate trial of topical therapy or phototherapy, systemic therapies including methotrexate, acitretin, or cyclosporin should be initiated. Because the regimens involved in systemic and phototherapy are complex and require frequent dose adjustments and specialized equipment, the patient should be referred to a dermatologist when topical therapy is not effective.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10625029     DOI: 10.1016/s0002-9343(99)00284-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  12 in total

1.  Expression profiles of elastase1 (NvElastaseI) and secretory leukocyte protease inhibitor (NvSLPI) during forelimb regeneration in adult Notophthalmus viridescens suggest a role in epithelial remodeling and delamination.

Authors:  Sandy Gian Vascotto; Shawn Beug; Richard A Liversage; Catherine Tsilfidis
Journal:  Dev Genes Evol       Date:  2006-03-01       Impact factor: 0.900

Review 2.  Comparative tolerability of systemic treatments for plaque-type psoriasis.

Authors:  Stacy L McClure; Jayme Valentine; Kenneth B Gordon
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

3.  Psoriasis exacerbation after hormonotherapy in prostate cancer patient-Case report.

Authors:  Ewa Ziółkowska; Marta Biedka; Agnieszka Zyromska; Roman Makarewicz
Journal:  Rep Pract Oncol Radiother       Date:  2010-07-06

4.  Quality of life in patients with psoriasis.

Authors:  Monali J Bhosle; Amit Kulkarni; Steven R Feldman; Rajesh Balkrishnan
Journal:  Health Qual Life Outcomes       Date:  2006-06-06       Impact factor: 3.186

5.  Superiority of a vitamin B12-containing emollient compared to a standard emollient in the maintenance treatment of mild-to-moderate plaque psoriasis.

Authors:  Ester Del Duca; Francesca Farnetani; Nathalie De Carvalho; Ugo Bottoni; Giovanni Pellacani; Steven P Nisticò
Journal:  Int J Immunopathol Pharmacol       Date:  2017-10-19       Impact factor: 3.219

6.  1,4-dihydroxy-2-naphthoic Acid Induces Apoptosis in Human Keratinocyte: Potential Application for Psoriasis Treatment.

Authors:  Chong-Fai Mok; Chuan-Ming Xie; Kathy Wai-Yan Sham; Zhi-Xiu Lin; Christopher Hon-Ki Cheng
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-11       Impact factor: 2.629

7.  HLA allele associations and V-beta T-lymphocyte expansions in patients with psoriasis, harboring toxin-producing Staphylococcus aureus.

Authors:  Rola Ajib; Lori Janbazian; Elias Rahal; Ghassan M Matar; Shukrallah Zaynoun; Abdul-Ghani Kibbi; Alexander M Abdelnoor
Journal:  J Biomed Biotechnol       Date:  2005

8.  CD1a expression in psoriatic skin following treatment with propylthiouracil, an antithyroid thioureylene.

Authors:  Alan N Elias; Vandana S Nanda; Ronald J Barr
Journal:  BMC Dermatol       Date:  2003-07-03

9.  Serum TNF-alpha in psoriasis after treatment with propylthiouracil, an antithyroid thioureylene.

Authors:  Alan N Elias; Vanda S Nanda; Raj Pandian
Journal:  BMC Dermatol       Date:  2004-04-30

10.  Root extract of water dropwort, Oenanthe javanica (Blume) DC, induces protein and gene expression of phase I carcinogen-metabolizing enzymes in HepG2 cells.

Authors:  Jae Kyeom Kim; Eui-Cheol Shin; Gwi Gun Park; Youn-Jung Kim; Dong-Hoon Shin
Journal:  Springerplus       Date:  2016-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.